Expansion and capacity Omega Bio-tek recently expanded its R&D facility in Oakbrook by about 50%, signaling increased capacity for product development and collaboration. This presents a sales opportunity to offer advanced nucleic acid purification technologies, high-throughput automation solutions, and support for scalable workflows to meet their growing demand.

Next-gen purification The company launched and showcased new Mag-Bind kits, including High Molecular Weight DNA and Total RNA Xpress products, targeting long-read sequencing and comprehensive RNA workflows. Sales opportunities exist to position premium extraction kits and automation-ready solutions for genomics, clinical research, and agricultural applications.

Automation partnerships Omega emphasizes automation platform support and strategic workflow collaborations, evidenced by SLAS conference participation and partnerships. There is a clear path to cross-sell automation integrations, validated workflows, and turnkey adapted systems for high-throughput labs and CROs.

Global reach With products deployed from small labs to large CROs worldwide and a diverse kit portfolio (over 900 SKUs), Omega can be approached for comprehensive nucleic acid purification ecosystems, customized kits, and regional distribution partnerships to expand market presence.

Quality and compliance ISO 9001:2015 and ISO 13485:2016 certification signals strong quality management for medical devices and biotech workflows. This alignment supports selling into regulated environments and negotiating partnerships that require robust quality assurance and documentation.